Abstract
Psoriasis is a chronic inflammatory skin disease, characterized by an enhanced proliferation and a deregulated differentiation of keratinocytes. hMena is an actin regulatory protein involved in the control of cell motility and adhesion. hMena results up-modulated in several human tumors with respect to normal tissues and its expression has been positively correlated to proliferation rate, tumor size and aggressiveness in response to mitogenic stimuli, such as epidermal growth factor. The hyperproliferation of keratinocytes observed in psoriasis prompted us to evaluate hMena expression on biopsies collected from involved and uninvolved skin of 12 patients with active plaque-type psoriasis with respect to healthy skin. We analyzed the expression of hMena at transcript and protein levels by quantitative RT-PCR and immunohistochemistry. We correlated the expression of hMena to Ki67 proliferation index and to keratin 10 (K10) and keratin 16 (K16) used as markers of keratinocyte differentiation and activation. We demonstrated the expression of hMena in a hyperproliferative skin condition not related to neoplastic transformation. Interestingly, we observed that hMena is not expressed in healthy skin, but it becomes detectable in non-lesional areas and it is even more expressed in lesional psoriatic skin. In addition, we found that hMena expression is correlated to the rate of keratinocyte proliferation and activation. Hence, our observations indicate hMena as a new possible player, involved in the development and/or maintenance of the hyperproliferative state of psoriatic keratinocytes.
This is a preview of subscription content, log in via an institution to check access.
References
Albanesi C, De Pità O, Girolomoni G (2007) Resident skin cells in psoriasis: a special look at the pathogenetic functions of keratinocytes. Clin Dermatol 25:581–588
Coppolino MG, Krause M, Hagendorff P et al (2001) Evidence for a molecular complex consisting of Fyb/SLAP, SLP-76, Nck, VASP and WASP that links the actin cytoskeleton to Fcgamma receptor signalling during phagocytosis. J Cell Sci 114:4307–4318
Di Modugno F, Mottolese M, Di Benedetto A et al (2006) The cytoskeleton regulatory protein hMena (ENAH) is overexpressed in human benign breast lesions with high risk of transformation and human epidermal growth factor receptor-2 positive/hormonal receptor-negative tumors. Clin Cancer Res 12:1470–1478
Di Modugno F, DeMonte L, Balsamo M et al (2007) Molecular cloning of hMena (ENAH) and its splice variant hMena +11a: epidermal growth factor increases their expression and stimulates hMena +11a phosphorylation in breast cancer cell lines. Cancer Res 67:2657–2665
Di Modugno F, Mottolese M, DeMonte L et al (2010) The cooperation between hMena overexpression and HER2 signalling in breast cancer. PLoS One 5:e15852
Fredriksson T, Pettersson U (1978) Severe psoriasis–oral therapy with a new retinoid. Dermatologica 157(4):238–244
Gurzu S, Jung I, Prantner I et al (2008) The expression of cytoskeleton regulatory protein Mena in colorectal lesions. Rom J Morphol Embryol 49(3):345–349
Gurzu S, Jung I, Prantner I et al (2009) The immunohistochemical aspects of protein Mena in cervical lesions. Rom J Morphol Embryol 50(2):213–216
Gurzu S, Krause M, Ember I et al (2012) Mena, a new available marker in tumors of salivary glands? Eur J of Histochem 56(1):e8
Kovacs D, Falchi M, Cardinali G et al (2005) Immunohistochemical analysis of keratinocyte growth factor and fibroblast growth factor 10 expression in psoriasis. Exp Dermatol 14:130–137
Krause M, Sechi AS, Konradt M et al (2000) Fyn-binding protein (Fyb)/SLP-76-associated protein (SLAP), Ena/vasodilator-stimulated phosphoprotein (VASP) proteins and the Arp2/3 complex link T cell receptor (TCR) signaling to the actin cytoskeleton. J Cell Biol 149:181–194
Krueger JG, Krane JF, Carter DM et al (1990) Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J Invest Dermatol 94:135S–140S
Pino MS, Balsamo M, Di Modugno F et al (2008) Human Mena +11a isoform serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cancer cell lines. Clin Cancer Res 14(15):4943–4950
Rashmi R, Rao KS, Basavaraj KH (2009) A comprehensive review of biomarkers in psoriasis. Clin Exp Dermatol 34:658–663
Toyofuku T, Zhang H, Kumanogoh A et al (2004) Guidance of myocardial patterning in cardiac development by Sema6D reverse signalling. Nat Cell Biol 6:1204–1211
Tschachler E (2007) Psoriasis: the epidermal component. Clin Dermatol 25:589–595
Acknowledgments
This study was in part supported by the Italian Ministry of Health Grant No 08/01/G/69.We thank Marco Zaccarini and Cinzia Di Mattia for technical assistance.
Conflict of interest
All authors state no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
G. Cardinali and D. Kovacs contributed equally to this work.
Rights and permissions
About this article
Cite this article
Cardinali, G., Kovacs, D., Mastrofrancesco, A. et al. hMena: altered expression in psoriatic skin. Arch Dermatol Res 305, 933–938 (2013). https://doi.org/10.1007/s00403-013-1358-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-013-1358-1